{"id":46052,"date":"2022-07-12T09:01:33","date_gmt":"2022-07-12T07:01:33","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\/"},"modified":"2022-07-12T09:01:33","modified_gmt":"2022-07-12T07:01:33","slug":"lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\/","title":{"rendered":"Lysando AG Strengthens Board of Directors by Appointment of Mr. Sang Jung Kim"},"content":{"rendered":"
\n

TRIESENBERG, Liechtenstein–(BUSINESS WIRE)–#Artilysin<\/a>–The market-leader for antimicrobial proteins, Lysando AG, has appointed Sang Jung Kim as new member to the Board of Directors. Kim has a strong Biotech background and a proven successful track record of more than 30 years experiences in relevant commercial areas. As Director of Sales & Marketing at AMICOGEN, a leading manufacturer of technical enzymes and strategic partner to the Lysando AG, he is already familiar to Lysando.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nKim joined AMICOGEN in March 2021, within the division for Enzyme and Biopharmaceuticals, responsible for Sales and Marketing Management as well as Business Development. Previously, from 1992 to 2021, he was employed at Novozymes, a leading company for Biological Solutions. During his career with Novozymes, he worked in the plant protection division, gained various experiences with enzymes in Technical Industries, Food, Feed & Bioenergy. Kim was further responsible for Sales and active within several management positions in Korea and Asia Pacific, lastly as the country manager for South Korea. Kim graduated from Seoul National University and holds a degree in Agricultural Chemistry.\n<\/p>\n

\n\u201cA few months after the start of our strategic partnership with AMICOGEN, the Board of Lysando is further strengthened. Sang Jung Kim and AMICOGEN share our entrepreneurial spirit and goal to prevent the antibiotic Armageddeon,” says the Chairman of the Board of Lysando AG, Count Markus Matuschka de Greiffenclau.\n<\/p>\n

\n\u201cFor AMICOGEN and for me, strategic partnership is not just an empty phrase: it is the commitment to a close shoulder-to-shoulder relationship. I am convinced that the great Lysando Artilysin\u00ae<\/sup> technology with AMICOGEN and combined forces will win the fight against resistant bacteria and for a healthy microbiome”, states Sang Jung Kim.\n<\/p>\n

\nThe Board of Directors officially added Sang Jung Kim on 1st<\/sup> February 2022.\n<\/p>\n

\nAbout Lysando AG<\/b>\n<\/p>\n

\nLysando AG is the market-leader for antimicrobial proteins, so-called Artilysin\u00aes.\n<\/p>\n

\nArtilysin\u00aes are a new class of molecules showing a high resistance stability and are microbiome- and environmentally-friendly. Artilysin\u00aes can be employed in all fields, bacteria present a problem like Medical Devices, Human Pharmaceutics, Animal Health and Consumer Care.\n<\/p>\n

\nThe R&D Facility of Lysando AG is Lysando Innovations Lab GmbH located in BioPark in Regensburg. BioPark Regensburg promotes biotechnology, medical technology, diagnostics & analytics as well as the health economy of the Regensburg area.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nVerena Schossmann
\n
+41(0)79 211 83 42
\n
Verena.Schossmann@lysando.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

TRIESENBERG, Liechtenstein–(BUSINESS WIRE)–#Artilysin–The market-leader for antimicrobial proteins, Lysando AG, has appointed Sang Jung Kim as new member to the Board of Directors. Kim has a strong Biotech background and a proven successful track record of more than 30 years experiences in relevant commercial areas. As Director of Sales & Marketing at AMICOGEN, a leading manufacturer … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46052","6":"format-standard","7":"category-industry"},"yoast_head":"\nLysando AG Strengthens Board of Directors by Appointment of Mr. Sang Jung Kim - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lysando AG Strengthens Board of Directors by Appointment of Mr. Sang Jung Kim - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"TRIESENBERG, Liechtenstein–(BUSINESS WIRE)–#Artilysin–The market-leader for antimicrobial proteins, Lysando AG, has appointed Sang Jung Kim as new member to the Board of Directors. Kim has a strong Biotech background and a proven successful track record of more than 30 years experiences in relevant commercial areas. As Director of Sales & Marketing at AMICOGEN, a leading manufacturer ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-12T07:01:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220712005115\/en\/1509466\/21\/sjk.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Lysando AG Strengthens Board of Directors by Appointment of Mr. Sang Jung Kim\",\"datePublished\":\"2022-07-12T07:01:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\\\/\"},\"wordCount\":396,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220712005115\\\/en\\\/1509466\\\/21\\\/sjk.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\\\/\",\"name\":\"Lysando AG Strengthens Board of Directors by Appointment of Mr. Sang Jung Kim - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220712005115\\\/en\\\/1509466\\\/21\\\/sjk.jpg\",\"datePublished\":\"2022-07-12T07:01:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220712005115\\\/en\\\/1509466\\\/21\\\/sjk.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220712005115\\\/en\\\/1509466\\\/21\\\/sjk.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lysando AG Strengthens Board of Directors by Appointment of Mr. Sang Jung Kim\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lysando AG Strengthens Board of Directors by Appointment of Mr. Sang Jung Kim - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\/","og_locale":"en_US","og_type":"article","og_title":"Lysando AG Strengthens Board of Directors by Appointment of Mr. Sang Jung Kim - Pharma Trend","og_description":"TRIESENBERG, Liechtenstein–(BUSINESS WIRE)–#Artilysin–The market-leader for antimicrobial proteins, Lysando AG, has appointed Sang Jung Kim as new member to the Board of Directors. Kim has a strong Biotech background and a proven successful track record of more than 30 years experiences in relevant commercial areas. As Director of Sales & Marketing at AMICOGEN, a leading manufacturer ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-12T07:01:33+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220712005115\/en\/1509466\/21\/sjk.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Lysando AG Strengthens Board of Directors by Appointment of Mr. Sang Jung Kim","datePublished":"2022-07-12T07:01:33+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\/"},"wordCount":396,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220712005115\/en\/1509466\/21\/sjk.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\/","url":"https:\/\/pharma-trend.com\/en\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\/","name":"Lysando AG Strengthens Board of Directors by Appointment of Mr. Sang Jung Kim - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220712005115\/en\/1509466\/21\/sjk.jpg","datePublished":"2022-07-12T07:01:33+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220712005115\/en\/1509466\/21\/sjk.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220712005115\/en\/1509466\/21\/sjk.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Lysando AG Strengthens Board of Directors by Appointment of Mr. Sang Jung Kim"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46052","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46052"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46052\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46052"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46052"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46052"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}